Intrinsic innate immunity fails to control herpes simplex virus and vesicular stomatitis virus replication in sensory neurons and fibroblasts

Journal of Virology

Volumn 88, Issue 17, 2014, Pages 9991-10001

  Rosato, Pamela C ^a   Leib, David A ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA INTERFERON;

ANIMAL; FIBROBLAST; IMMUNOLOGY; INNATE IMMUNITY; KNOCKOUT MOUSE; MOUSE; PHYSIOLOGY; SENSORY NERVE CELL; SIMPLEXVIRUS; VESICULOVIRUS; VIROLOGY; VIRUS REPLICATION;

ANIMALS; FIBROBLASTS; IMMUNITY, INNATE; INTERFERON-BETA; MICE; MICE, KNOCKOUT; SENSORY RECEPTOR CELLS; SIMPLEXVIRUS; VESICULOVIRUS; VIRUS REPLICATION;

EID: 84921943673     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01462-14     Document Type: Article

References (90)

1. Smith JS, Robinson NJ. 2002. Age-specific prevalence of infection with herpes simplex virus types 2 and 1: a global review. J. Infect. Dis. 186:S3-S28. http://dx.doi.org/10.1086/343739.
2. Gilden DH, Mahalingam R, Cohrs RJ, Tyler KL. 2007. Herpesvirus infections of the nervous system. Nat. Clin. Pract. Neurol. 3:82-94. http://dx.doi.org/10.1038/ncpneuro0401.
3. Smith G. 2012. Herpesvirus transport to the nervous system and back again. Annu. Rev. Microbiol. 66:153-176. http://dx.doi.org/10.1146/annurev-micro-092611-150051.
4. Dupuis S, Jouanguy E, Al-Hajjar S, Fieschi C, Al-Mohsen IZ, Al-Jumaah S, Yang K, Chapgier A, Eidenschenk C, Eid P, Ghonaium AA, Tufenkeji H, Frayha H, Al-Gazlan S, Al-Rayes H, Schreiber RD, Gresser I, Casanova J-L. 2003. Impaired response to interferon-[alpha]/[beta] and lethal viral disease in human STAT1 deficiency. Nat. Genet. 33:388-391. http://dx.doi.org/10.1038/ng1097.
5. Casrouge A, Zhang S-Y, Eidenschenk C, Jouanguy E, Puel A, Yang K, Alcais A, Picard C, Mahfoufi N, Nicolas N, Lorenzo L, Plancoulaine S, Sénéchal B, Geissmann F, Tabeta K, Hoebe K, Du X, Miller RL, Héron B, Mignot C, de Villemeur TB, Lebon P, Dulac O, Rozenberg F, Beutler B, Tardieu M, Abel L, Casanova J-L. 2006. Herpes simplex virus encephalitis in human UNC-93B deficiency. Science 314:308-312. http://dx.doi.org/10.1126/science.1128346.
6. Zhang S-Y, Jouanguy E, Ugolini S, Smahi A, Elain G, Romero P, Segal D, Sancho-Shimizu V, Lorenzo L, Puel A, Picard C, Chapgier A, Plancoulaine S, Titeux M, Cognet C, von Bernuth H, Ku C-L, Casrouge A, Zhang X-X, Barreiro L, Leonard J, Hamilton C, Lebon P, Héron B, Vallée L, Quintana-Murci L, Hovnanian A, Rozenberg F, Vivier E, Geissmann F, Tardieu M, Abel L, Casanova J-L. 2007. TLR3 deficiency in patients with herpes simplex encephalitis. Science 317:1522-1527. http://dx.doi.org/10.1126/science.1139522.
7. Pérez de Diego R, Sancho-Shimizu V, Lorenzo L, Puel A, Plancoulaine S, Picard C, Herman M, Cardon A, Durandy A, Bustamante J, Vallabhapurapu S, Bravo J, Warnatz K, Chaix Y, Cascarrigny F, Lebon P, Rozenberg F, Karin M, Tardieu M, Al-Muhsen S, Jouanguy E, Zhang S-Y, Abel L, Casanova J-L. 2010. Human TRAF3 adaptor molecule deficiency leads to impaired Toll-like receptor 3 response and susceptibility to herpes simplex encephalitis. Immunity 33:400-411. http://dx.doi.org/10.1016/j.immuni.2010.08.014.
8. Menachery VD, Pasieka TJ, Leib DA. 2010. Interferon regulatory factor 3-dependent pathways are critical for control of herpes simplex virus type 1 central nervous system infection. J. Virol. 84:9685-9694. http://dx.doi.org/10.1128/JVI.00706-10.
9. Leib DA, Harrison TE, Laslo KM, Machalek MA, Moorman NJ, Virgin HW. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189:663-672. http://dx.doi.org/10.1084/jem.189.4.663.
10. Luker GD, Prior JL, Song J, Pica CM, Leib DA. 2003. Bioluminescence imaging reveals systemic dissemination of herpes simplex virus type 1 in the absence of interferon receptors. J. Virol. 77:11082-11093. http://dx.doi.org/10.1128/JVI.77.20.11082-11093.2003.
11. Paludan SR, Bowie AG, Horan KA, Fitzgerald KA. 2011. Recognition of herpesviruses by the innate immune system. Nat. Rev. Immunol. 11:143-154. http://dx.doi.org/10.1038/nri2937.
12. Schindler C, Levy DE, Decker T. 2007. JAK-STAT signaling: from interferons to cytokines. J. Biol. Chem. 282:20059-20063. http://dx.doi.org/10.1074/jbc.R700016200.
13. Levy DE, Marié IJ, Durbin JE. 2011. Induction and function of type I and III interferon in response to viral infection. Curr. Opin. Virol. 1:476-486. http://dx.doi.org/10.1016/j.coviro.2011.11.001.
14. Leib DA. 2002. Counteraction of interferon-induced antiviral responses by herpes simplex viruses. Curr. Top. Microbiol. Immunol. 269:171-185.
15. Paladino P, Mossman KL. 2009. Mechanisms employed by herpes simplex virus 1 to inhibit the interferon response. J. Interferon Cytokine Res. 29:599-607. http://dx.doi.org/10.1089/jir.2009.0074.
16. Chou J, Kern ER, Whitley RJ, Roizman B. 1990. Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science 250:1262-1266. http://dx.doi.org/10.1126/science.2173860.
17. Li Y, Zhang C, Chen X, Yu J, Wang Y, Yang Y, Du M, Jin H, Ma Y, He B, Cao Y. 2011. ICP34.5 protein of herpes simplex virus facilitates the initiation of protein translation by bridging eukaryotic initiation factor 2alpha (eIF2alpha) and protein phosphatase 1. J. Biol. Chem. 286:24785-24792. http://dx.doi.org/10.1074/jbc.M111.232439.
18. Verpooten D, Ma Y, Hou S, Yan Z, He B. 2009. Control of TANKbinding kinase 1-mediated signaling by the gamma(1)34.5 protein of herpes simplex virus 1. J. Biol. Chem. 284:1097-1105. http://dx.doi.org/10.1074/jbc.M805905200.
19. Orvedahl A, Alexander D, Tallóczy Z, Sun Q, Wei Y, Zhang W, Burns D, Leib DA, Levine B. 2007. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1:23-35. http://dx.doi.org/10.1016/j.chom.2006.12.001.
20. Gobeil PAM, Leib DA. 2012. Herpes simplex virus? 34.5 interferes with autophagosome maturation and antigen presentation in dendritic cells. mBio 3(5):e00267-12. http://dx.doi.org/10.1128/mBio.00267-12.
21. Rampling R, Cruickshank G, Papanastassiou V, Nicoll J, Hadley D, Brennan D, Petty R, MacLean A, Harland J, McKie E, Mabbs R, Brown M. 2000. Toxicity evaluation of replication-competent herpes simplex virus (ICP 34.5 null mutant 1716) in patients with recurrent malignant glioma. Gene Ther. 7:859-866. http://dx.doi.org/10.1038/sj.gt.3301184.
22. Leib DA, Machalek MA, Williams BR, Silverman RH, Virgin HW. 2000. Specific phenotypic restoration of an attenuated virus by knockout of a host resistance gene. Proc. Natl. Acad. Sci. U. S. A. 97:6097-6101. http://dx.doi.org/10.1073/pnas.100415697.
23. Thompson RL, Stevens JG. 1983. Biological characterization of a herpes simplex virus intertypic recombinant which is completely and specifically non-neurovirulent. Virology 131:171-179. http://dx.doi.org/10.1016/0042-6822(83)90543-3.
24. Yordy B, Iijima N, Huttner A, Leib D, Iwasaki A. 2012. A neuronspecific role for autophagy in antiviral defense against herpes simplex virus. Cell Host Microbe 12:334-345. http://dx.doi.org/10.1016/j.chom.2012.07.013.
25. He C, Klionsky DJ. 2009. Regulation mechanisms and signaling pathways of autophagy. Annu. Rev. Genet. 43:67-93. http://dx.doi.org/10.1146/annurev-genet-102808-114910.
26. Kroemer G, Mariño G, Levine B. 2010. Autophagy and the integrated stress response. Mol. Cell 40:280-293. http://dx.doi.org/10.1016/j.molcel.2010.09.023.
27. Carr DJJ, Al-Khatib Khaldun James CM, Silverman R. 2003. Interferon-β suppresses herpes simplex virus type 1 replication in trigeminal ganglion cells through an RNase L-dependent pathway. J. Neuroimmunol. 141:40-46. http://dx.doi.org/10.1016/S0165-5728(03)00216-9.
28. Svennerholm B, Ziegler R, Lycke E. 1989. Herpes simplex virus infection of the rat sensory neuron effects of interferon on cultured cells. Arch. Virol. 104:153-156. http://dx.doi.org/10.1007/BF01313816.
29. De Regge N, Van Opdenbosch N, Nauwynck HJ, Efstathiou S, Favoreel HW. 2010. Interferon alpha induces establishment of alphaherpesvirus latency in sensory neurons in vitro. PLoS One 5:e13076. http://dx.doi.org/10.1371/journal.pone.0013076.
30. Wigdahl BL, Ziegler RJ, Sneve M, Rapp F. 1983. Herpes simplex virus latency and reactivation in isolated rat sensory neurons. Virology 127: 159-167. http://dx.doi.org/10.1016/0042-6822(83)90380-X.
31. Lafaille FG, Pessach IM, Zhang S-Y, Ciancanelli MJ, Herman M, Abhyankar A, Ying S-W, Keros S, Goldstein PA, Mostoslavsky G, Ordovas-Montanes J, Jouanguy E, Plancoulaine S, Tu E, Elkabetz Y, Al-Muhsen S, Tardieu M, Schlaeger TM, Daley GQ, Abel L, Casanova J-L, Studer L, Notarangelo LD. 2012. Impaired intrinsic immunity to HSV-1 in human iPSC-derived TLR3-deficient CNS cells. Nature 491:769-773. http://dx.doi.org/10.1038/nature11583.
32. Wilson AC, Mohr I. 2012. A cultured affair: HSV latency and reactivation in neurons. Trends Microbiol. 20:604-611. http://dx.doi.org/10.1016/j.tim.2012.08.005.
33. Hafezi W, Lorentzen EU, Eing BR, Müller M, King NJC, Klupp B, Mettenleiter TC, Kühn JE. 2012. Entry of herpes simplex virus type 1 (HSV-1) into the distal axons of trigeminal neurons favors the onset of nonproductive, silent infection. PLoS Pathog. 8:e1002679. http://dx.doi.org/10.1371/journal.ppat.1002679.
34. Kobayashi M, Kim J-Y, Camarena V, Roehm PC, Chao MV, Wilson AC, Mohr I. 2012. A primary neuron culture system for the study of herpes simplex virus latency and reactivation. J. Vis. Exp. http://dx.doi.org/10.3791/3823.
35. Farmer JR, Altschaefl KM, O'Shea KS, Miller DJ. 2013. Activation of the type I interferon pathway is enhanced in response to human neuronal differentiation. PLoS One 8:e58813. http://dx.doi.org/10.1371/journal.pone.0058813.
36. Cho H, Proll SC, Szretter KJ, Katze MG, Gale M, Jr, Diamond MS. 2013. Differential innate immune response programs in neuronal subtypes determine susceptibility to infection in the brain by positivestranded RNA viruses. Nat. Med. 19:458-464. http://dx.doi.org/10.1038/nm.3108.
37. Bertke AS, Swanson SM, Chen J, Imai Y, Kinchington PR, Margolis TP. 2011. A5-positive primary sensory neurons are nonpermissive for productive infection with herpes simplex virus 1 in vitro. J. Virol. 85:6669-6677. http://dx.doi.org/10.1128/JVI.00204-11.
38. Harkness JM, Kader M, DeLuca NA. 2014. Transcription of the herpes simplex virus 1 genome during productive and quiescent infection of neuronal and nonneuronal cells. J. Virol. 88:6847-6861. http://dx.doi.org/10.1128/JVI.00516-14.
39. Bertke AS, Ma A, Margolis MS, Margolis TP. 2013. Different mechanisms regulate productive herpes simplex virus 1 (HSV-1) and HSV-2 infections in adult trigeminal neurons. J. Virol. 87:6512-6516. http://dx.doi.org/10.1128/JVI.00383-13.
40. Bertke AS, Apakupakul K, Ma A, Imai Y, Gussow AM, Wang K, Cohen JI, Bloom DC, Margolis TP. 2012. LAT region factors mediating differential neuronal tropism of HSV-1 and HSV-2 do not act in trans. PLoS One 7:e53281. http://dx.doi.org/10.1371/journal.pone.0053281.
41. Stewart WE, II, Scott WD, Sulkin SE. 1969. Relative sensitivities of viruses to different species of interferon. J. Virol. 4:147-153.
42. Rubinstein S, Familletti PC, Pestka S. 1981. Convenient assay for interferons. J. Virol. 37:755-758.
43. Tsukamoto LF, Price RW. 1982. Interferon protects neurons in culture infected with vesicular stomatitis and herpes simplex viruses. J. Neurol. Sci. 56:115-128. http://dx.doi.org/10.1016/0022-510X(82)90066-1.
44. Trottier MD, Jr, Palian BM, Reiss CS. 2005. VSV replication in neurons is inhibited by type I IFN at multiple stages of infection. Virology 333:215-225. http://dx.doi.org/10.1016/j.virol.2005.01.009.
45. Detje CN, Meyer T, Schmidt H, Kreuz D, Rose JK, Bechmann I, Prinz M, Kalinke U. 2009. Local type I IFN receptor signaling protects against virus spread within the central nervous system. J. Immunol. 182:2297-2304.
46. Fensterl V, Wetzel JL, Ramachandran S, Ogino T, Stohlman SA, Bergmann CC, Diamond MS, Virgin HW, Sen GC. 2012. Interferon-induced Ifit2/ISG54 protects mice from lethal VSV neuropathogenesis. PLoS Pathog. 8:e1002712. http://dx.doi.org/10.1371/journal.ppat.1002712.
47. Liu Y-J. 2005. IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu. Rev. Immunol. 23:275-306. http://dx.doi.org/10.1146/annurev.immunol.23.021704.115633.
48. Colonna M, Trinchieri G, Liu Y-J. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5:1219-1226. http://dx.doi.org/10.1038/ni1141.
49. Rasmussen SB, Sørensen LN, Malmgaard L, Ank N, Baines JD, Chen ZJ, Paludan SR. 2007. Type I interferon production during herpes simplex virus infection is controlled by cell-type-specific viral recognition through Toll-like receptor 9, the mitochondrial antiviral signaling protein pathway, and novel recognition systems. J. Virol. 81:13315-13324. http://dx.doi.org/10.1128/JVI.01167-07.
50. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, Nakao K, Nakaya T, Katsuki M, Noguchi S, Tanaka N, Taniguchi T. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-alpha/beta gene induction. Immunity 13:539-548. http://dx.doi.org/10.1016/S1074-7613(00)00053-4.
51. Choi MK, Wang Z, Ban T, Yanai H, Lu Y, Koshiba R, Nakaima Y, Hangai S, Savitsky D, Nakasato M, Negishi H, Takeuchi O, Honda K, Akira S, Tamura T, Taniguchi T. 2009. A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA. Proc. Natl. Acad. Sci. http://dx.doi.org/10.1073/pnas.0909545106.
52. Randall RE, Goodbourn S. 2008. Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J. Gen. Virol. 89:1-47. http://dx.doi.org/10.1099/vir.0.83391-0.
53. Rader KA, Ackland-Berglund CE, Miller JK, Pepose JS, Leib DA. 1993. In vivo characterization of site-directed mutations in the promoter of the herpes simplex virus type 1 latency-associated transcripts. J. Gen. Virol. 74(Part 9):1859-1869.
54. Showalter SD, Zweig M, Hampar B. 1981. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP 4. Infect. Immun. 34:684-692.
55. Smith KO. 1964. Relationship between the envelope and the infectivity of herpes simplex virus. Proc. Soc. Exp. Biol. Med. 115:814-816. http://dx.doi.org/10.3181/00379727-115-29045.
56. Alexander DE, Ward SL, Mizushima N, Levine B, Leib DA. 2007. Analysis of the role of autophagy in replication of herpes simplex virus in cell culture. J. Virol. 81:12128-12134. http://dx.doi.org/10.1128/JVI.01356-07.
57. English L, Chemali M, Duron J, Rondeau C, Laplante A, Gingras D, Alexander D, Leib D, Norbury C, Lippé R, Desjardins M. 2009. Autophagy enhances the presentation of endogenous viral antigens onMHC class I molecules during HSV-1 infection. Nat. Immunol. 10:480-487. http://dx.doi.org/10.1038/ni.1720.
58. Brown SM, Ritchie DA, Subak-Sharpe JH. 1973. Genetic studies with herpes simplex virus type 1. The isolation of temperature-sensitive mutants, their arrangement into complementation groups and recombination analysis leading to a linkage map. J. Gen. Virol. 18:329-346.
59. Stow ND, Stow EC. 1986. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate early polypeptide Vmw110. J. Gen. Virol. 67(Part 12): 2571-2585.
60. Ishikawa H, Barber GN. 2008. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling. Nature 455:674-678. http://dx.doi.org/10.1038/nature07317.
61. Durbin JE, Hackenmiller R, Simon MC, Levy DE. 1996. Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease. Cell 84:443-450. http://dx.doi.org/10.1016/S0092-8674(00)81289-1.
62. Van den Broek MF, Muller U, Huang S, Aguet M, Zinkernagel RM. 1995. Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors. J. Virol. 69:4792-4796.
63. Murphy AA, Rosato PC, Parker ZM, Khalenkov A, Leib DA. 2013. Synergistic control of herpes simplex virus pathogenesis by IRF-3, and IRF-7 revealed through non-invasive bioluminescence imaging. Virology 444:71-79. http://dx.doi.org/10.1016/j.virol.2013.05.034.
64. Dix RD, McKendall RR, Baringer JR. 1983. Comparative neurovirulence of herpes simplex virus type 1 strains after peripheral or intracerebral inoculation of BALB/c mice. Infect. Immun. 40:103-112.
65. Krug A, Luker GD, Barchet W, Leib DA, Akira S, Colonna M. 2004. Herpes simplex virus type 1 activates murine natural interferonproducing cells through Toll-like receptor 9. Blood 103:1433-1437. http://dx.doi.org/10.1182/blood-2003-08-2674.
66. Swiecki M, Wang Y, Gilfillan S, Colonna M. 2013. Plasmacytoid dendritic cells contribute to systemic but not local antiviral responses to HSV infections. PLoS Pathog. 9:e1003728. http://dx.doi.org/10.1371/journal.ppat.1003728.
67. Conley AJ, Knipe DM, Jones PC, Roizman B. 1981. Molecular genetics of herpes simplex virus. VII. Characterization of a temperature-sensitive mutant produced by in vitro mutagenesis and defective in DNA synthesis and accumulation of gamma polypeptides. J. Virol. 37:191-206.
68. Reich NC, Liu L. 2006. Tracking STAT nuclear traffic. Nat. Rev. Immunol. 6:602-612. http://dx.doi.org/10.1038/nri1885.
69. Chesler DA, Dodard C, Lee GY, Levy DE, Reiss CS. 2004. Interferongamma-induced inhibition of neuronal vesicular stomatitis virus infection is STAT1 dependent. J. Neurovirol. 10:57-63. http://dx.doi.org/10.1080/13550280490261707.
70. Kato H, Takeuchi O, Sato S, Yoneyama M, Yamamoto M, Matsui K, Uematsu S, Jung A, Kawai T, Ishii KJ, Yamaguchi O, Otsu K, Tsujimura T, Koh C-S, Reis e Sousa C, Matsuura Y, Fujita T, Akira S. 2006. Differential roles of MDA5 and RIG-I helicases in the recognition of RNA viruses. Nature 441:101-105. http://dx.doi.org/10.1038/nature04734.
71. Katzenell S, Chen Y, Parker ZM, Leib DA. 2014. The differential interferon responses of two strains of Stat1-deficient mice do not alter susceptibility to HSV-1 and VSV in vivo. Virology 451:350-354. http://dx.doi.org/10.1016/j.virol.2013.12.015.
72. Low-Calle AM, Prada-Arismendy J, Castellanos JE. 2013. Study of interferon-β antiviral activity against herpes simplex virus type 1 in neuronenriched trigeminal ganglia cultures. Virus Res. 180:49-58. http://dx.doi.org/10.1016/j.virusres.2013.12.022.
73. Mossman KL, Saffran HA, Smiley JR. 2000. Herpes simplex virus ICP0 mutants are hypersensitive to interferon. J. Virol. 74:2052-2056. http://dx.doi.org/10.1128/JVI.74.4.2052-2056.2000.
74. Härle P, Sainz B, Jr, Carr DJJ, Halford WP. 2002. The immediate-early protein, ICP0, is essential for the resistance of herpes simplex virus to interferon-alpha/beta. Virology 293:295-304. http://dx.doi.org/10.1006/viro.2001.1280.
75. Chou J, Roizman B. 1992. The gamma 1(34.5) gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells. Proc. Natl. Acad. Sci. U. S. A. 89:3266-3270. http://dx.doi.org/10.1073/pnas.89.8.3266.
76. Conrady CD, Jones H, Zheng M, Carr DJJ. 2011. A functional type I interferon pathway drives resistance to cornea herpes simplex virus type 1 infection by recruitment of leukocytes. J. Biomed. Res. 25:111-119. http://dx.doi.org/10.1016/S1674-8301(11)60014-6.
77. Wang JP, Bowen GN, Zhou S, Cerny A, Zacharia A, Knipe DM, Finberg RW, Kurt-Jones EA. 2012. Role of specific innate immune responses in herpes simplex virus infection of the central nervous system. J. Virol. 86: 2273-2281. http://dx.doi.org/10.1128/JVI.06010-11.
78. Kallfass C, Ackerman A, Lienenklaus S, Weiss S, Heimrich B, Staeheli P. 2012. Visualizing production of beta interferon by astrocytes and microglia in brain of La Crosse virus-infected mice. J. Virol. 86:11223-11230. http://dx.doi.org/10.1128/JVI.01093-12.
79. Roth-Cross JK, Bender SJ, Weiss SR. 2008. Murine coronavirus mouse hepatitis virus is recognized by MDA5 and induces type I interferon in brain macrophages/microglia. J. Virol. 82:9829-9838. http://dx.doi.org/10.1128/JVI.01199-08.
80. Nichol PF, Chang JY, Johnson EM, Jr, Olivo PD. 1996. Herpes simplex virus gene expression in neurons: viral DNA synthesis is a critical regulatory event in the branch point between the lytic and latent pathways. J. Virol. 70:5476-5486.
81. Kemp LM, Dent CL, Latchman DS. 1990. Octamer motif mediates transcriptional repression of HSV immediate-early genes and octamercontaining cellular promoters in neuronal cells. Neuron 4:215-222. http://dx.doi.org/10.1016/0896-6273(90)90096-X.
82. Alexander DE, Leib DA. 2008. Xenophagy in herpes simplex virus replication and pathogenesis. Autophagy 4:101-103.
83. Schmeisser H, Bekisz J, Zoon KC. 2014. New function of type I IFN-: induction of autophagy. J. Interferon Cytokine Res. 34:71-78. http://dx.doi.org/10.1089/jir.2013.0128.
84. Schmeisser H, Fey SB, Horowitz J, Fischer ER, Balinsky CA, Miyake K, Bekisz J, Snow AL, Zoon KC. 2013. Type I interferons induce autophagy in certain human cancer cell lines. Autophagy 9:683-696. http://dx.doi.org/10.4161/auto.23921.
85. Matsuzawa T, Kim B-H, Shenoy AR, Kamitani S, Miyake M, Macmicking JD. 2012. IFN-γ elicits macrophage autophagy via the p38 MAPK signaling pathway. J. Immunol. 189:813-818. http://dx.doi.org/10.4049/jimmunol.1102041.
86. Chang JY, Martin DP, Johnson EM. 1990. Interferon suppresses sympathetic neuronal cell death caused by nerve growth factor deprivation. J. Neurochem. 55:436-445. http://dx.doi.org/10.1111/j.1471-4159.1990.tb04155.x.
87. Yang CH, Murti A, Pfeffer SR, Basu L, Kim JG, Pfeffer LM. 2000. IFN-α/β promotes cell survival by activating NF-κB. Proc. Natl. Acad. Sci. U. S. A. 97:13631-13636. http://dx.doi.org/10.1073/pnas.250477397.
88. Samuel MA, Diamond MS. 2005. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79:13350-13361. http://dx.doi.org/10.1128/JVI.79.21.13350-13361.2005.
89. Jin S, Kawanokuchi J, Mizuno T, Wang J, Sonobe Y, Takeuchi H, Suzumura A. 2007. Interferon-beta is neuroprotective against the toxicity induced by activated microglia. Brain Res. 1179:140-146. http://dx.doi.org/10.1016/j.brainres.2007.08.055.
90. Balachandran S, Roberts PC, Kipperman T, Bhalla KN, Compans RW, Archer DR, Barber GN. 2000. Alpha/beta interferons potentiate virusinduced apoptosis through activation of the FADD/caspase-8 death signaling pathway. J. Virol. 74:1513-1523. http://dx.doi.org/10.1128/JVI.74.3.1513-1523.2000.